Nutritional and metabolic support in the adult intensive care unit: Key controversies

Critical Care Medicine

Volumn 34, Issue 5, 2006, Pages 1525-1531

  Bistrian, Bruce R ^a   McCowen, Karen C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DIABETES CONTROL; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMMUNOMODULATION; INSULIN RELEASE; INTENSIVE CARE UNIT; METABOLIC REGULATION; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SURGICAL PATIENT; CRITICAL ILLNESS; HYPERGLYCEMIA; METHODOLOGY; TOTAL PARENTERAL NUTRITION;

IMMUNOLOGICAL ADJUVANT;

ADJUVANTS, IMMUNOLOGIC; ADULT; CRITICAL ILLNESS; ENTERAL NUTRITION; HUMANS; HYPERGLYCEMIA; INTENSIVE CARE UNITS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION, TOTAL;

EID: 33646551751     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000216704.54446.FD     Document Type: Article

References (66)

1. Heyland DK, Dhaliwal R, Drover JW, et al: Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355-373
2. Furnary AP, Zerr KJ, Grunkemeier GL, et al: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-360
3. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001; 17:107-124
4. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22:77-81
5. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345:1359-1367
6. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
7. Lelkes E, Unsworth BR, Lelkes PI: Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: An in vitro cellular model for diabetic neuropathy. Neurotox Res 2001; 3:189-203
8. Ling PR, Mueller C, Smith RJ, et al: Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism 2003; 52:868-874
9. Kyselova P, Zourek M, Rusavy Z, et al: Hyperinsulinemia and oxidative stress. Physiol Res 2002; 51:591-595
10. Krogh-Madsen R, Moller K, Dela F, et al: Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-α, and FFA to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004; 286:E766-E772
11. Hansen TK, Thiel S, Wouters PJ, et al: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:1082-1088
12. Jeschke MG, Klein D, Herndon DN: Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239:553-560
13. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047
14. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478
15. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
16. Malmberg K, Ryden L, Hamsten A, et al: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction: DIGAMI Study Group (Diabetes Insulin-Glucose in Acute Myocardial Infarction). Eur Heart J 1996; 17:1337-1344
17. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314:1512-1515
18. Sodi-Pallares D, Ponce de Leon J, Bisteni A, et al: Potassium, glucose, and insulin in myocardial infarction. Lancet 1969; 1:1315-1316
19. Malmberg K, Ryden L, Wedel H, et al., DIGAMI 2 Investigators: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005; 26:639-641
20. Timmer JR, van der Horst IC, Ottervanger JP, et al: Glucose-insulin- potassium infusion as adjunctive therapy in myocardial infarction: Current evidence and potential mechanisms. Ital Heart J 2004; 5:727-731
21. Mehta SR, Yusuf S, Diaz R, et al: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446
22. Apstein CS, Opie LH: A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 2005; 26:956-959
23. McCowen KC, Bistrian BR: Immunonutrition: Problematic or problem solving? Am J Clin Nutr 2003; 77:764-770
24. Daly JM, Reynolds J, Thom A, et al: Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208:512-523
25. Barbul A, Sisto DA, Wasserkrug HL, et al: Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 1981; 90:244-251
26. Kirk SJ, Hurson M, Regan MC, et al: Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993; 114:155-159
27. Brown RO, Hunt H, Mowatt-Larssen CA, et al: Comparison of specialized and standard enteral formulas in trauma patients. Pharmacotherapy 1994; 14:314-320
28. Mendez C, Jurkovich GJ, Garcia I, et al: Effects of an immune-enhancing diet in critically injured patients. J Trauma 1997; 42:933-940
29. Wachtler P, Konig W, Senkal M, et al: Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997; 42:191-198
30. Serhan CN, Arita M, Hong S, et al: Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004; 39:1125-1132
31. McCowen KC, Bistrian BR: Essential fatty acids and their derivatives. Curr Opin Gastroenterol 2005; 21:207-215
32. Bistrian BR: Practical recommendations for immune-enhancing diets. J Nutr 2004; 134:2868S-2872S
33. Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994; 1213:277-288
34. Burdge GC, Finnegan YE, Minihane AM, et al: Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards betaoxidation in older men. Br J Nutr 2003; 90:311-321
35. Wu D, Meydani SN, Meydani M, et al: Immunologic effects of marine- and plant-derived n-3 polyunsaturated fatty acids in nonhuman primates. Am J Clin Nutr 1996; 63:273-280
36. Caparros T, Lopez J, Grau T: Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet: The effect on nosocomial infections and outcome. JPEN J Parenter Enteral Nutr 2001; 25:299-308
37. Mayer K, Seeger W, Grimminger F: Clinical use of lipids to control inflammatory disease. Curr Opin Clin Nutr Metab Care 1998; 1:179-184
38. Moore FA, Moore EE, Kudsk KA, et al: Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37:607-615
39. Kudsk KA, Minard G, Croce MA, et al: A randomized trial of isonitrogenous enteral diets after severe trauma: An immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:531-540
40. Galban C, Montejo JC, Mesejo A, et al: An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643-648
41. Atkinson S, Sieffert E, Bihari D: A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit Care Med 1998; 26:1164-1672
42. Bower RH, Cerra FB, Bershadsky B, et al: Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449
43. Kieft H, Roos AN, van Drunen JD, et al: Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med 2005; 31:524-532
44. Braga M, Vignali A, Gianotti L, et al: Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg 1996; 162:105-112
45. Chuntrasakul C, Siltham S, Sarasombath S, et al: Comparison of a immunonutrition formula enriched arginine, glutamine and omega-3 fatty acid, with a currently high enriched enteral nutrition for trauma patients. J Med Assoc Thai 2003; 86:552-561
46. Gottschlich MM, Jenkins M, Warden GD, et al: Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 1990; 14:225-236
47. Saffle JR, Wiebke G, Jennings K, et al: Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma 1997; 42:793-800
48. Beale RJ, Bryg DJ, Bihari DJ: Immunonutrition in the critically ill: A systematic review of clinical outcome. Crit Care Med 1999; 27:2799-2805
49. Heys SD, Walker LG, Smith I, et al: Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: A meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229:467-477
50. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953
51. Montejo JC, Zarazaga A, Lopez-Martinez J, et al: Immunonutrition in the intensive care unit: A systematic review and consensus statement. Clin Nutr 2003; 22:221-233
52. Bertolini G, Iapichino G, Radrizzani D, et al: Early enteral immunonutrition in patients with severe sepsis: Results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003; 29:834-840
53. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
54. VA TPN Cooperative Study. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991; 325:525-532
55. Simpson F, Doig GS: Parenteral vs. enteral nutrition in the critically ill patient: A meta-analysis of trials using the intention to treat principle. Intensive Care Med 2005; 31:12-23
56. Peter JV, Moran JL, Phillips-Hughes J: A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med 2005; 33:213-220
57. Marik PE, Zaloga GP: Early enteral nutrition in acutely ill patients: A systematic review. Crit Care Med 2001; 29:2264-2270
58. Martin CM, Doig GS, Heyland DK, et al: Multicentre, cluster randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ 2004; 170:197-204
59. Barr J, Hecht M, Flavin KE, et al: Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest 2004; 125:1446-1457
60. Mackenzie SL, Zygun DA, Whitmore BL, et al: Implementation of a nutrition support protocol increases the proportion of mechanically ventilated patients reaching enteral nutrition targets in the adult intensive care unit. JPEN J Parenter Enteral Nutr 2005; 29:74-80
61. Heyland DK, Dhaliwal R, Day A, et al: Validation of the Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients: Results of a prospective observational study. Crit Care Med 2004; 32:2260-2266
62. Hall JC, Dobb G, Hall J, et al: A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 2003; 29:1710-1716
63. Woodcock NP, Zeigler D, Palmer MD, et al: Enteral versus parenteral nutrition: a pragmatic study. Nutrition 2001; 17:1-12
64. Maykel JA, Pazirandeh S, Bistrian BR: Is there a benefit to postpyloric feeding? Crit Care Med 2002; 30:1654-1656
65. Maykel JA, Bistrian BR: Is enteral feeding for everyone? Crit Care Med 2002; 30:714-716
66. Weimann A, Bastian L, Bischoff WE, et al: Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 1998; 14:165-72